Homologous Recombination Assay Kit

Cat. 35600
  • Professional Tech Support with Senior R&D Scientist
  • Fast and Flexible Ordering Options (online, email, or phone)
  • Volume Discounts Available on Large Quantity Orders*

*Inquire by phone or email for more information.


Homologous Recombination Assay Kit

Cat. 35600

Rapid and sensitive tool for measuring the efficiency of homologous recombination

  • Rapid and sensitive tool for measuring the efficiency of homologous recombination
  • For any cell types including prokaryotes and eukaryotes
  • All primers included for quantification of the homologous recombination efficiency through qPCR.

For research use only and NOT intended for in vitro diagnostics.

Want a discount?

Create your account to receive 15% off on your first purchase!

Homologous Recombination Assay Kit
(Cat. 35600)
200 transformations / 24 transfections

Product Size

Kit Specifications

You have selected: Cat. 35600

Homologous Recombination Assay Kit Contents:
1.  dl-1 Plasmid
2.  dl-2 Plasmid
3.  Positive Control Plasmid
4.  Assay Primers Mixture
5.  Universal Primers Mixture
6.  Nuclease-Free Water
7.  Product Insert

SHELF LIFE AND HANDLING
All solutions should be kept tightly sealed and stored at -20oC or lower temperature for up to 1 year without any reduction in kit performance.

Supporting Data

Click for expanded view

Title Replicative Stress Coincides with Impaired Nuclear DNA Damage Response in COX4-1 Deficiency
Journal Int. J. Mol. Sci.. 2022.
Authors Liza Douiev , Chaya Miller, Guy Keller, Hadar Benyamini, Bassam Abu-Libdeh and Ann Saada
Title Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.
Journal Clin Cancer Res. 2022.
Authors Maria R. Baer, Aksinija A. Kogan, Søren M. Bentzen, Tian Mi, Rena G. Lapidus, Vu H. Duong, Ashkan Emadi, Sandrine Niyongere, Casey L. O'Connell, Benjamin A. Youngblood, Stephen B. Baylin, Feyruz V. Rassool
Title Modulation of BRCA1 mediated DNA damage repair by deregulated ER-α signaling in breast cancers
Journal Am J Cancer Res. 2022.
Authors Arathi Rajan, Geetu R Varghese, Induprabha Yadev, Jaimie Anandan, Neetha R Latha, Dipyaman Patra, Neethu Krishnan, Krithiga Kuppusamy, Arathy V Warrier, Satej Bhushan, Revathy Nadhan, Ram Mohan Ram Kumar, and Priya Srinivas
Title Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51
Journal Molecular Therapy. 2018.
Authors Eun Ju Lee, Injoo Hwang, Ji Yeon Lee, Jong Nam Park, Keun Cheon Kim, Gi-Hwam Kim, Chang-Mo Kang, Irene Kim, Seo-Yeon Lee, Hyo-Soo Kim
Title Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas
Journal Oncotarget. 2017.
Authors Muh-Lii Liang, Tsung-Han Hsieh, Yun-Ru Liu, Yi-Wei Chen, Yi-Yen Lee, Feng-Chi Chang, Shih-Chiej Lin, Ming-Chao Huang, Donald Ming-Tak Ho, Tai-Tong Wong, Yun Yen, and Muh-Hwa Yang
Title Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
Journal Journal of Experimental & Clinical Research. 2017.
Authors Xin Zhang, Ran Xu, Chao Zhang, Yangyang Xu, Mingzhi Han, Bin Huang, Anjing Chen, Chen Qui, Frits Thorsenm Lars Prestegarden, Rolf Bjerkvig, Jian Wang and Xingang Li
Title 14-3-3sigma Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle via PARP1 and CHK2
Journal Molecular Cancer Research. 2017.
Authors Chen Y, Li Z, Dong Z, Beebe J, Yang K, Fu L, Zhang JT.
Title Effect of endonuclease G depletion on plasmid DNA uptake and levels of homologous recombination in hela cells
Journal Molecular Cell Biology. 2016.
Authors V. Misic, M. El-Mogy, S. Geng, Y. Haj-Ahmad
Title Protein–Protein Interaction Inhibitors of BRCA1 Discovered Using Small Molecule Microarrays
Journal Small Molecule Microarrays. 2016.
Authors Na Z, Pan S, Uttamchandani M, Yao SQ.
Title Hypoxia Differentially Modulates the Genomic Stability of Clinical-Grade ADSCs and BM-MSCs in Long-Term Culture
Journal Stem Cells. 2015
Authors Bigot N, Mouche A, Preti M, Loisel S, Renoud ML, Le Guével R, Sensebé L, Tarte K, Pedeux R
Title Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.
Journal Molecular Cancer Research. 2015
Authors Maachani UB, Kramp T, Hanson R, Zhao S, Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K, Tandle A
Title Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance.
Journal Cancer Research. 2014.
Authors Ohba S, Mukherjee J, See WL, Pieper RO.

Homologous Recombination Assay Kit

Norgen’s Homologous Recombination Assay Kit provides a rapid and sensitive tool for measuring the efficiency of homologous recombination in both bacterial and mammalian cells. The kit consists of 5 components: (1) dl-1 plasmid, (2) dl-2 plasmid, (3) positive control plasmid, (4) assay primers mixture, and (5) universal primers mixture. The assay is based on the co-transformation of the two dl plasmids into bacterial cells followed by the isolation of plasmid DNA and quantification of the homologous recombination efficiency through qPCR. In addition, PCR can be used for qualitative analysis of the recombination efficiency. The primer mixture provided with the kit is designed to amplify only the homologous recombination product but not the dl plasmids (dl-1 or dl-2). The two plasmids can be co-transfected into mammalian cells, then the DNA can be isolated and the homologous recombination efficiency can be assayed by qPCR (or PCR). In addition, the efficiency of homologous recombination can be assessed in bacteria by blue/white screening using X-gal. The provided positive control contains the functional LacZ sequence and can be used as a positive control for the plasmid DNA isolation efficiency (after transformation or transfection) or PCRs. The use of PCR-based homologous recombination assay enhances the sensitivity and eliminates the need for labor intensive screening by using traditional protein expression and staining techniques and is suitable for high throughput screening studies.  The kit is designed to perform 200 transformations or 24 transfections.

  • Rapid and sensitive tool - All primers included to allow for measuring the efficiency of homologous recombination through PCR or qPCR
  • For any cell types - Kit can be used to measure efficiency of homolgous recombination in both prokaryotes and eukaryotes

Supporting Data

Click for expanded view

Kit Specifications

You have selected: Cat. 35600

Homologous Recombination Assay Kit Contents:
1.  dl-1 Plasmid
2.  dl-2 Plasmid
3.  Positive Control Plasmid
4.  Assay Primers Mixture
5.  Universal Primers Mixture
6.  Nuclease-Free Water
7.  Product Insert

SHELF LIFE AND HANDLING
All solutions should be kept tightly sealed and stored at -20oC or lower temperature for up to 1 year without any reduction in kit performance.

Title Replicative Stress Coincides with Impaired Nuclear DNA Damage Response in COX4-1 Deficiency
Journal Int. J. Mol. Sci.. 2022.
Authors Liza Douiev , Chaya Miller, Guy Keller, Hadar Benyamini, Bassam Abu-Libdeh and Ann Saada
Title Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.
Journal Clin Cancer Res. 2022.
Authors Maria R. Baer, Aksinija A. Kogan, Søren M. Bentzen, Tian Mi, Rena G. Lapidus, Vu H. Duong, Ashkan Emadi, Sandrine Niyongere, Casey L. O'Connell, Benjamin A. Youngblood, Stephen B. Baylin, Feyruz V. Rassool
Title Modulation of BRCA1 mediated DNA damage repair by deregulated ER-α signaling in breast cancers
Journal Am J Cancer Res. 2022.
Authors Arathi Rajan, Geetu R Varghese, Induprabha Yadev, Jaimie Anandan, Neetha R Latha, Dipyaman Patra, Neethu Krishnan, Krithiga Kuppusamy, Arathy V Warrier, Satej Bhushan, Revathy Nadhan, Ram Mohan Ram Kumar, and Priya Srinivas
Title Hepatocyte Growth Factor Improves the Therapeutic Efficacy of Human Bone Marrow Mesenchymal Stem Cells via RAD51
Journal Molecular Therapy. 2018.
Authors Eun Ju Lee, Injoo Hwang, Ji Yeon Lee, Jong Nam Park, Keun Cheon Kim, Gi-Hwam Kim, Chang-Mo Kang, Irene Kim, Seo-Yeon Lee, Hyo-Soo Kim
Title Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas
Journal Oncotarget. 2017.
Authors Muh-Lii Liang, Tsung-Han Hsieh, Yun-Ru Liu, Yi-Wei Chen, Yi-Yen Lee, Feng-Chi Chang, Shih-Chiej Lin, Ming-Chao Huang, Donald Ming-Tak Ho, Tai-Tong Wong, Yun Yen, and Muh-Hwa Yang
Title Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
Journal Journal of Experimental & Clinical Research. 2017.
Authors Xin Zhang, Ran Xu, Chao Zhang, Yangyang Xu, Mingzhi Han, Bin Huang, Anjing Chen, Chen Qui, Frits Thorsenm Lars Prestegarden, Rolf Bjerkvig, Jian Wang and Xingang Li
Title 14-3-3sigma Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle via PARP1 and CHK2
Journal Molecular Cancer Research. 2017.
Authors Chen Y, Li Z, Dong Z, Beebe J, Yang K, Fu L, Zhang JT.
Title Effect of endonuclease G depletion on plasmid DNA uptake and levels of homologous recombination in hela cells
Journal Molecular Cell Biology. 2016.
Authors V. Misic, M. El-Mogy, S. Geng, Y. Haj-Ahmad
Title Protein–Protein Interaction Inhibitors of BRCA1 Discovered Using Small Molecule Microarrays
Journal Small Molecule Microarrays. 2016.
Authors Na Z, Pan S, Uttamchandani M, Yao SQ.
Title Hypoxia Differentially Modulates the Genomic Stability of Clinical-Grade ADSCs and BM-MSCs in Long-Term Culture
Journal Stem Cells. 2015
Authors Bigot N, Mouche A, Preti M, Loisel S, Renoud ML, Le Guével R, Sensebé L, Tarte K, Pedeux R
Title Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.
Journal Molecular Cancer Research. 2015
Authors Maachani UB, Kramp T, Hanson R, Zhao S, Celiku O, Shankavaram U, Colombo R, Caplen NJ, Camphausen K, Tandle A
Title Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance.
Journal Cancer Research. 2014.
Authors Ohba S, Mukherjee J, See WL, Pieper RO.

Related Products